Icodextrin dialysate improves nutritional and inflammatory profiles in peritoneal dialysis patients

Wei Lin, Yung Chih Chen, Mai Szu Wu, Heng Jung Hsu, Chiao Yin Sun, Ying Kuang Lin, I. Wen Wu

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background. Previous studies demonstrate that icodextrin is superior to 4.25% dextrose for fluid removal in patients with high and high-average transport membrane. Recent studies reveal that controlling volume status improves malnutrition in peritoneal dialysis (PD) patients. This study hypothesized that icodextrin enhances nutritional and inflammatory status by improving fluid balance. Methods. This retrospective case-control study investigated the effects of icodextrin on patient nutritional profiles over a one-year period. Thirty-two patients who used icodextrin for more than one year were classified as the "icodextrin group." Ten patients who used glucose-containing dialysate without icodextrin were classified as the control group. Clinical and laboratory parameters were compared between groups. Demographic and laboratory parameters were analyzed at baseline, 3 months, 6 months, and 12 months after starting icodextrin dialysis. Results. Ultrafiltration of icodextrin per exchange in the icodextrin group was 66% higher than that for 4.25% dextrose exchange in the icodextrin group (icodextrin vs. 4.25% dextrose: 492.1 ± 204.5 vs. 296.1 ± 115.3 mL/exchange; p <0.0001, paired t-test). The increased albumin and normalized protein catabolic rate (nPCR) after icodextrin for one year was unique for the icodextrin group (p <0.0001 and p <0.0001, respectively). The inflammatory marker high sensitivity C-reactive protein (hsCRP) decreased significantly only in the icodextrin group (p = 0.0048). Conclusion. Icodextrin dialysate may improve nutritional and inflammatory status in PD patients. However, the long-term clinical effects of icodextrin require further study.

Original languageEnglish
Pages (from-to)98-105
Number of pages8
JournalRenal Failure
Volume31
Issue number2
DOIs
Publication statusPublished - Feb 2009
Externally publishedYes

Fingerprint

Dialysis Solutions
Peritoneal Dialysis
Glucose
icodextrin
Nutritional Status
Water-Electrolyte Balance
Ultrafiltration
Malnutrition
C-Reactive Protein

Keywords

  • Icodextrin
  • Inflammation
  • Nutrition
  • Peritoneal dialysis

ASJC Scopus subject areas

  • Nephrology
  • Critical Care and Intensive Care Medicine

Cite this

Icodextrin dialysate improves nutritional and inflammatory profiles in peritoneal dialysis patients. / Lin, Wei; Chen, Yung Chih; Wu, Mai Szu; Hsu, Heng Jung; Sun, Chiao Yin; Lin, Ying Kuang; Wu, I. Wen.

In: Renal Failure, Vol. 31, No. 2, 02.2009, p. 98-105.

Research output: Contribution to journalArticle

Lin, Wei ; Chen, Yung Chih ; Wu, Mai Szu ; Hsu, Heng Jung ; Sun, Chiao Yin ; Lin, Ying Kuang ; Wu, I. Wen. / Icodextrin dialysate improves nutritional and inflammatory profiles in peritoneal dialysis patients. In: Renal Failure. 2009 ; Vol. 31, No. 2. pp. 98-105.
@article{79ffc0b67bc1462ea8cdc40f040eaa51,
title = "Icodextrin dialysate improves nutritional and inflammatory profiles in peritoneal dialysis patients",
abstract = "Background. Previous studies demonstrate that icodextrin is superior to 4.25{\%} dextrose for fluid removal in patients with high and high-average transport membrane. Recent studies reveal that controlling volume status improves malnutrition in peritoneal dialysis (PD) patients. This study hypothesized that icodextrin enhances nutritional and inflammatory status by improving fluid balance. Methods. This retrospective case-control study investigated the effects of icodextrin on patient nutritional profiles over a one-year period. Thirty-two patients who used icodextrin for more than one year were classified as the {"}icodextrin group.{"} Ten patients who used glucose-containing dialysate without icodextrin were classified as the control group. Clinical and laboratory parameters were compared between groups. Demographic and laboratory parameters were analyzed at baseline, 3 months, 6 months, and 12 months after starting icodextrin dialysis. Results. Ultrafiltration of icodextrin per exchange in the icodextrin group was 66{\%} higher than that for 4.25{\%} dextrose exchange in the icodextrin group (icodextrin vs. 4.25{\%} dextrose: 492.1 ± 204.5 vs. 296.1 ± 115.3 mL/exchange; p <0.0001, paired t-test). The increased albumin and normalized protein catabolic rate (nPCR) after icodextrin for one year was unique for the icodextrin group (p <0.0001 and p <0.0001, respectively). The inflammatory marker high sensitivity C-reactive protein (hsCRP) decreased significantly only in the icodextrin group (p = 0.0048). Conclusion. Icodextrin dialysate may improve nutritional and inflammatory status in PD patients. However, the long-term clinical effects of icodextrin require further study.",
keywords = "Icodextrin, Inflammation, Nutrition, Peritoneal dialysis",
author = "Wei Lin and Chen, {Yung Chih} and Wu, {Mai Szu} and Hsu, {Heng Jung} and Sun, {Chiao Yin} and Lin, {Ying Kuang} and Wu, {I. Wen}",
year = "2009",
month = "2",
doi = "10.1080/08860220802595500",
language = "English",
volume = "31",
pages = "98--105",
journal = "Renal Failure",
issn = "0886-022X",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Icodextrin dialysate improves nutritional and inflammatory profiles in peritoneal dialysis patients

AU - Lin, Wei

AU - Chen, Yung Chih

AU - Wu, Mai Szu

AU - Hsu, Heng Jung

AU - Sun, Chiao Yin

AU - Lin, Ying Kuang

AU - Wu, I. Wen

PY - 2009/2

Y1 - 2009/2

N2 - Background. Previous studies demonstrate that icodextrin is superior to 4.25% dextrose for fluid removal in patients with high and high-average transport membrane. Recent studies reveal that controlling volume status improves malnutrition in peritoneal dialysis (PD) patients. This study hypothesized that icodextrin enhances nutritional and inflammatory status by improving fluid balance. Methods. This retrospective case-control study investigated the effects of icodextrin on patient nutritional profiles over a one-year period. Thirty-two patients who used icodextrin for more than one year were classified as the "icodextrin group." Ten patients who used glucose-containing dialysate without icodextrin were classified as the control group. Clinical and laboratory parameters were compared between groups. Demographic and laboratory parameters were analyzed at baseline, 3 months, 6 months, and 12 months after starting icodextrin dialysis. Results. Ultrafiltration of icodextrin per exchange in the icodextrin group was 66% higher than that for 4.25% dextrose exchange in the icodextrin group (icodextrin vs. 4.25% dextrose: 492.1 ± 204.5 vs. 296.1 ± 115.3 mL/exchange; p <0.0001, paired t-test). The increased albumin and normalized protein catabolic rate (nPCR) after icodextrin for one year was unique for the icodextrin group (p <0.0001 and p <0.0001, respectively). The inflammatory marker high sensitivity C-reactive protein (hsCRP) decreased significantly only in the icodextrin group (p = 0.0048). Conclusion. Icodextrin dialysate may improve nutritional and inflammatory status in PD patients. However, the long-term clinical effects of icodextrin require further study.

AB - Background. Previous studies demonstrate that icodextrin is superior to 4.25% dextrose for fluid removal in patients with high and high-average transport membrane. Recent studies reveal that controlling volume status improves malnutrition in peritoneal dialysis (PD) patients. This study hypothesized that icodextrin enhances nutritional and inflammatory status by improving fluid balance. Methods. This retrospective case-control study investigated the effects of icodextrin on patient nutritional profiles over a one-year period. Thirty-two patients who used icodextrin for more than one year were classified as the "icodextrin group." Ten patients who used glucose-containing dialysate without icodextrin were classified as the control group. Clinical and laboratory parameters were compared between groups. Demographic and laboratory parameters were analyzed at baseline, 3 months, 6 months, and 12 months after starting icodextrin dialysis. Results. Ultrafiltration of icodextrin per exchange in the icodextrin group was 66% higher than that for 4.25% dextrose exchange in the icodextrin group (icodextrin vs. 4.25% dextrose: 492.1 ± 204.5 vs. 296.1 ± 115.3 mL/exchange; p <0.0001, paired t-test). The increased albumin and normalized protein catabolic rate (nPCR) after icodextrin for one year was unique for the icodextrin group (p <0.0001 and p <0.0001, respectively). The inflammatory marker high sensitivity C-reactive protein (hsCRP) decreased significantly only in the icodextrin group (p = 0.0048). Conclusion. Icodextrin dialysate may improve nutritional and inflammatory status in PD patients. However, the long-term clinical effects of icodextrin require further study.

KW - Icodextrin

KW - Inflammation

KW - Nutrition

KW - Peritoneal dialysis

UR - http://www.scopus.com/inward/record.url?scp=61649089516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61649089516&partnerID=8YFLogxK

U2 - 10.1080/08860220802595500

DO - 10.1080/08860220802595500

M3 - Article

VL - 31

SP - 98

EP - 105

JO - Renal Failure

JF - Renal Failure

SN - 0886-022X

IS - 2

ER -